Top Sell
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.88 | - | - |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.55 | - | - |
| Applied Therapeutics Inc | 1 | 1 | 0 | 1 | €4.49 | €4.00 | -10.834% |
| Arca Biopharma | 1 | 22 | 1 | 2 | €3.18 | €6.00 | 88.679% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.66 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.52 | €3.00 | 475.374% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.10 | €6.49 | 489.859% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €41.07 | €67.64 | 64.692% |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 1 | €3.20 | €5.00 | 56.250% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.42 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.99 | €3.00 | 50.754% |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Cytomx Therapeutics Inc | 4 | 3 | 4 | 3 | €2.18 | €50.00 | 2197.794% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.01 | - | - |
| Evoke Pharma Inc. | 0 | 23 | 0 | 1 | €0.43 | - | - |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €1.16 | €0.000 | -100.000% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.90 | €6.53 | 629.721% |
| Illumina Inc. | 18 | 4 | 3 | 1 | €102.48 | €169.78 | 65.668% |
| Integra LifeSciences Holdings Corp | 3 | 5 | 0 | 2 | €23.00 | €34.68 | 50.776% |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | €0.33 | €1.60 | 379.042% |